-
Loading metrics
Application of Allogeneic Bone Marrow Cells in View of Residual Alloreactivity: Sirolimus but Not Cyclosporine Evolves Tolerogenic Properties
- Kai Timrott,
- Florian W. R. Vondran,
- Hueseyin Bektas,
- Jürgen Klempnauer,
- Mark D. Jäger
x
- Published: April 2, 2015
- https://doi.org/10.1371/journal.pone.0119950